Further analysis revealed that a high expression of RFC4 also indicates poor prognosis, even when accompanied by high levels of tumor-infiltrating immune cells, including CD4+ T cells, CD8+ T cells, B cells, dendritic cells and monocytes (Figure 9C). Here, RFC4 is linked to neoplasm.